Key department responsible for the overall management of intellectual properties and patents of the CHA Medical Group

Contributing towards the innovative global level of R&BD commercialization by supervising overall work related to operation and support of the research center.

Open platform providing experimental services in in vivo/vitro efficacy testing and histological analysis

Specialized research in embryonic stem cell maintenance, differentiation and applications.

Focused on revealing the potential of human fetal stem cells as therapeutics and understanding their therapeutic mechanisms

Outlining the physiological functions, pathological implications, and clinical applications of embryonic germline stem cells.

Understanding the mechanism of how oncolytic viruses, a new class of tumor immunotherapy, mediate antitumor activity

Discovering and developing novel treatments through the knowledge of therapeutic targets and early enhanced drug discovery

Research on health functional food materials and health care-related materials using natural products and microorganisms

Driving breakthrough discoveries in proactive skin care using bioderma-related to technology and substances